logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2011 or most recent year available

Part (iii) Inpatient clients by primary drug and mean age, gender ratio

Primary drugMean ageGender ratio
Amphetamines302
Ecstasy283
 

Notes:

For information relative to the countries included please see Table TDI-7

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2012 — Standard table 3. See Table TDI-0 for details on sources. See also TDI-5.

Page last updated: Friday, 26 April 2013